Inventor
BAI XU
JP29 patents
⚠️ This page may combine multiple inventors who share the name “BAI XU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEC CORP
12 patentsUS10044355B2Aug 7, 2018
Reconfigurable circuit with crossbar switches including non-volatile resistive switches
NEC CORP2 citations72
US10424617B2Sep 24, 2019
Crossbar switch with an arrangement of wires, logic integrated circuit using the same, and semiconductor device
NEC CORP0 citations52
US11018671B2May 25, 2021
Reconfigurable circuit and the method for using the same
NEC CORP0 citations51
US10879902B2Dec 29, 2020
Reconfigurable circuit using nonvolatile resistive switches
NEC CORP0 citations51
US10812076B2Oct 20, 2020
Logic integrated circuit and semiconductor device
NEC CORP0 citations51
US10720925B2Jul 21, 2020
Integrated circuit
NEC CORP0 citations51
US10305485B2May 28, 2019
Programmable logic integrated circuit, semiconductor device, and characterization method
NEC CORP0 citations51
US10027326B2Jul 17, 2018
Reconfigurable circuit
NEC CORP1 citations51
US10855283B2Dec 1, 2020
Routing network for reconfigurable circuit
NEC CORP0 citations41
US10748614B2Aug 18, 2020
Semiconductor device and programming method therefor
NEC CORP0 citations41
US10740435B2Aug 11, 2020
Programmable logic integrated circuit, design support system, and configuration method
NEC CORP0 citations41
US10396798B2Aug 27, 2019
Reconfigurable circuit
NEC CORP0 citations41
IDUN PHARMACEUTICALS INC
8 patentsUS6200969B1Mar 13, 2001
Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
IDUN PHARMACEUTICALS INC38 citations92
US6184244B1Feb 6, 2001
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
IDUN PHARMACEUTICALS INC46 citations92
US5869519AFeb 9, 1999
C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
IDUN PHARMACEUTICALS INC56 citations92
US6693096B2Feb 17, 2004
Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
IDUN PHARMACEUTICALS INC11 citations73
US6610683B2Aug 26, 2003
Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
IDUN PHARMACEUTICALS INC4 citations62
US6531467B2Mar 11, 2003
Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
IDUN PHARMACEUTICALS INC5 citations59
US6528506B2Mar 4, 2003
Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
IDUN PHARMACEUTICALS INC4 citations59
US6489353B2Dec 3, 2002
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
IDUN PHARMACEUTICALS INC1 citations52
NANOBRIDGE SEMICONDUCTOR INC
3 patentsUS11481535B2Oct 25, 2022
Numerical information generation apparatus, numerical information generation method, and program
NANOBRIDGE SEMICONDUCTOR INC0 citations60
US10979053B2Apr 13, 2021
Logic integrated circuit
NANOBRIDGE SEMICONDUCTOR INC0 citations60
US11139024B2Oct 5, 2021
Semiconductor device
NANOBRIDGE SEMICONDUCTOR INC0 citations49